Investigation Overview
An investigation on behalf of investors in shares of Catasys, Inc. (NASDAQ: CATS) was announced over potential breaches of fiduciary duties by certain officers and directors at Catasys, Inc.
The investigation by a law firm concerns whether certain Catasys, Inc.officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Los Angeles, CA Catasys, Inc. provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. Catasys, Inc. reported that its annual Total Revenue rose from $7.07 million in 2016 to $7.71 million in 2017 and that its Net Loss declined from $17.93 million in 2016 to $13.6 million in 2017.
Shares of Catasys, Inc. (NASDAQ: CATS) reached as high as $12.18 per share in March 2017 and declined to as low as $3.30 per share in late 2017.